Moss, S.M.

screening cancer prostate cancer prostate group study death control erspc effect control arm sensitivity number trial center result mortality european analysis incidence reduction control group finland interval contamination netherland schr öder fh screening group prostate-cancer follow-up estimate treatment european randomised study sweden university nejm.org test sensitivity 69 years table england journal european randomized study urology medicine downloaded erasmus university screening round randomised department randomized round model antigen roobol health rotterdam biopsy nonattendance life-year koning hj prostate-cancer mortality utility copyright adjustment utility estimates e ng l roobol mj centre subject randomization <3 ng /ml downloaded prostate cancer screening base model erasmu screening interval society massachusett method cohort population prostate-specific